Adults 45 to 64, any sex, with Auditory Perception. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Comparison of How Four Models of Personal Listening Devices Improve Word Understanding in NoisePrimary· One 2-hour lab session
Improvement in performance on speech perception task using the Nuheara IQ Buds, Tweak Focus, Bose Hearphones, or the Sound World Solutions CS 50+ personal listening devices, measured by percentage of words accurately recalled in noise with device minus percentage recalled without device. Positive values indicate improvement in performance.
Group
Value
95% CI
Tweak Focus
1.65
± 6.40
CS50+
0.85
± 7.01
IQ Buds
7.35
± 6.03
Bose
10.24
± 8.23
Difference in Self-rated Listening EffortSecondary· One 2-hour session
Effect of listening devices on subjective listening effort, measured by rating on ten-point scale (10 = greatest amount of effort) after task performed with device minus rating after task performed without device. Lower scores indicate less listening effort; negative values indicate reduction in effort with device.
Group
Value
95% CI
Tweak Focus
-1.4
± 1.26
CS50+
-1.4
± 1.84
IQ Buds
-0.9
± 1.29
Bose
-1.8
± 1.81
Sponsor's own description
This study will measure the performance of three personal amplification devices when used by middle-aged adults. Speech understanding will be assessed with two different types of background noises at three different input levels.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Amherst
Last refreshed: 17 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03704142.